The bill modifies the existing drug take-back program in Washington State by amending several sections of the Revised Code of Washington (RCW) to enhance reporting, compliance, and fee structures. Key changes include the requirement for program operators to submit detailed annual reports that now must include specific information about collection amounts, public education efforts, and future goals. Additionally, the bill introduces new compliance measures, allowing the Department of Health to audit drug take-back programs and enforce penalties for noncompliance. The department is also tasked with evaluating these reports for adherence to the law and approved plans.

Furthermore, the bill establishes a one-time fee of $70,000 to be evenly distributed among approved program operators to fund an expedited review of the department's fee-setting authority. This review, to be conducted by the Joint Legislative Audit and Review Committee, aims to ensure that the fees cover actual administrative costs and that expenditures are transparent. The bill also includes provisions for the repeal of certain sections of the RCW related to the drug take-back program, effective January 1, 2030, indicating a significant restructuring of the program's regulatory framework.

Statutes affected:
Original Bill: 69.48.100, 69.48.110, 69.48.120, 69.48.130, 43.131.424
Substitute Bill: 69.48.100, 69.48.110, 69.48.120, 69.48.130
Second Substitute: 69.48.100, 69.48.110, 69.48.120, 69.48.130
Engrossed Second Substitute: 69.48.100, 69.48.110, 69.48.120, 43.131.424
Bill as Passed Legislature: 69.48.100, 69.48.110, 69.48.120, 43.131.424
Session Law: 69.48.100, 69.48.110, 69.48.120, 43.131.424